Terms: = Gastric cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Treatment
12 results:
1. gastric metastasis from breast cancer: five cases and a single-institutional review.
Cheng M; Jia Z; Zhang G; Wang Y; Li S; Yang S; Li C; Geng C
J Int Med Res; 2024 Mar; 52(3):3000605241233988. PubMed ID: 38483129
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological Features and Prognosis of Gastrointestinal Metastases From Breast Carcinoma: A Clinicopathological Study of 22 Patients.
Wang S; Li W; Li S; Liu X; Zhang L; Hao C; Meng W; Zhao W; Tong Z
Int J Surg Pathol; 2023 Sep; 31(6):1075-1084. PubMed ID: 36803140
[No Abstract] [Full Text] [Related]
3. Upregulation of exonuclease 1 caused by homology-dependent repair confers cisplatin resistance to gastric cancer cells.
Mao P; Wu S; Fan Y
Can J Physiol Pharmacol; 2022 Sep; 100(9):903-914. PubMed ID: 35767882
[TBL] [Abstract] [Full Text] [Related]
4. [A Case of Simultaneous Double cancer with gastric Metastasis of Breast cancer and Lung cancer].
Maekawa T; Kaida S; Ishikawa K; Yamaguchi T; Takebayashi K; Maehira H; Miyake T; Ueki T; Iida H; Tani M
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2024-2026. PubMed ID: 33468788
[TBL] [Abstract] [Full Text] [Related]
5. Dose reduction in hdr brachytherapy of esophageal cancer using gold and gold alloy plaques: a Monte Carlo study.
Masoudi SF; Baratian S; Asadi S; Rasouli FS
Radiat Environ Biophys; 2021 Mar; 60(1):115-124. PubMed ID: 33389051
[TBL] [Abstract] [Full Text] [Related]
6. gastric and adrenal metastasis from breast cancer: Case report and review of literature.
Tang T; Zhang L; Li C; Zhou T
Medicine (Baltimore); 2020 Jan; 99(3):e18812. PubMed ID: 32011488
[TBL] [Abstract] [Full Text] [Related]
7. Paclitaxel‑resistant gastric cancer MGC‑803 cells promote epithelial‑to‑mesenchymal transition and chemoresistance in paclitaxel‑sensitive cells via exosomal delivery of miR‑155‑5p.
Wang M; Qiu R; Yu S; Xu X; Li G; Gu R; Tan C; Zhu W; Shen B
Int J Oncol; 2019 Jan; 54(1):326-338. PubMed ID: 30365045
[TBL] [Abstract] [Full Text] [Related]
8. A quality assurance device for measuring afterloader performance and transit dose for nasobiliary high-dose-rate brachytherapy.
Deufel CL; Mullins JP; Zakhary MJ
Brachytherapy; 2018; 17(4):726-731. PubMed ID: 29779953
[TBL] [Abstract] [Full Text] [Related]
9. Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study.
Lee B; Ahn SH; Kim H; Son J; Sung J; Han Y; Huh SJ; Kim JS; Kim DW; Yoon M
J Appl Clin Med Phys; 2016 Sep; 17(5):124-132. PubMed ID: 27685104
[TBL] [Abstract] [Full Text] [Related]
10. [Screening for predictive biomarkers of bevacizumab treatment in gastric cancer subcutaneous xenografts].
Zhang Q; Xu J; Ye J; Yuan Y; Chen J; Peng J; He Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Feb; 18(2):177-80. PubMed ID: 25656129
[TBL] [Abstract] [Full Text] [Related]
11. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.
Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471
[TBL] [Abstract] [Full Text] [Related]
12. Lymph node metastasis and preoperative diagnosis of depth of invasion in early gastric cancer.
Seto Y; Shimoyama S; Kitayama J; Mafune K; Kaminishi M; Aikou T; Arai K; Ohta K; Nashimoto A; Honda I; Yamagishi H; Yamamura Y
Gastric Cancer; 2001; 4(1):34-8. PubMed ID: 11706625
[TBL] [Abstract] [Full Text] [Related]
